The Quiet Battle Over Compounding — and Why Colorado’s SB 26-066 Matters Now
From renewed FDA scrutiny to sharp criticism from segments of organized medicine, and even debates spilling into mainstream media, compounded medications have become the focus of a growing national conversation. At first glance, the issue is framed as one of safety. But as with many things in medicine, the reality is more nuanced. And now, […]